Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IBOC
IBOC logo

IBOC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy International Bancshares Corp (IBOC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
71.160
1 Day change
-1.86%
52 Week Range
75.440
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

International Bancshares Corp (IBOC) is not a strong buy for a beginner, long-term investor at this moment. While the technical indicators show a bullish trend and hedge funds are significantly increasing their positions, the lack of recent news catalysts, declining financial performance in net income and EPS, and no significant options activity or trading signals suggest a wait-and-see approach. The investor's impatience and preference for long-term investments make this stock a hold for now.

Technical Analysis

The technical indicators are moderately bullish. The MACD is above 0 and positively contracting, the RSI is neutral at 64.461, and the moving averages (SMA_5 > SMA_20 > SMA_200) indicate a bullish trend. The stock is trading near its resistance level of 72.782, with support at 70.643.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 5879.88% increase in buying over the last quarter.

Neutral/Negative Catalysts

  • No significant insider trading activity. Financial performance shows a decline in net income (-7.13% YoY) and EPS (-7.03% YoY). No recent news or event-driven catalysts. No recent congress trading data.

Financial Performance

In Q4 2025, revenue increased by 5.80% YoY to $216.42M. However, net income dropped by 7.13% YoY to $106.88M, and EPS fell by 7.03% YoY to 1.72. Gross margin remained flat.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes available.

Wall Street analysts forecast IBOC stock price to rise
Analyst Rating
0
Wall Street analysts forecast IBOC stock price to rise
Buy
Hold
Sell
0
Current: 72.510
sliders
Low
0
Averages
0
High
0
0
Current: 72.510
sliders
Low
0
Averages
0
High
0
Freedom Capital
Amirlan Kalymbekov
Buy
initiated
$85
AI Analysis
2025-12-31
Reason
Freedom Capital
Amirlan Kalymbekov
Price Target
$85
AI Analysis
2025-12-31
initiated
Buy
Reason
Freedom Capital analyst Amirlan Kalymbekov initiated coverage of International Bancshares with a Buy rating and $85 price target. While the bank has elevated commercial real estate concentration, interest-rate sensitivity, and exposure to cross-border activity, the firm sees these factors being balanced by strong profitability supported by "best-in-class" efficiency and conservative balance sheet positioning, the analyst tells investors.

People Also Watch